Foresite Capital Management IV, LLC Diversified Active

CIK: 0001704132 · Show all filings

Period: Q2 2025 (← Previous) (Next →)

Filing Date: Aug 12, 2025

Total Value ($000): $123,796 (100.0% shares, 0.0% debt)

Holdings (6)

PHVS Pharvaris N.V. 62.7%

Value ($000) $77,626 Shares 4,410,581 Est. Cost $27.29 Unrealized -41.0%

MAZE Maze Therapeutics Inc 20.9%

Value ($000) $25,913 Shares 2,111,919 Est. Cost $12.04 Unrealized -13.6%

LYEL Lyell Immunopharma, Inc. 5.7%

Value ($000) $7,076 Shares 800,399 Est. Cost $9.11 Unrealized 0.0%

XENE Xenon Pharmaceuticals Inc 4.0%

Value ($000) $5,008 Shares 160,000 Est. Cost $32.62 Unrealized 0.0%

KURA Kura Oncology, Inc. 3.8%

Value ($000) $4,713 Shares 816,882 Est. Cost $20.39 Unrealized -70.0%

RLAY Relay Therapeutics Inc. 2.8%

Value ($000) $3,460 Shares 1,000,000 Est. Cost $7.47 Unrealized -60.2%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
PHVS	Pharvaris N.V.	4,410,581	$77,626	62.7%	$27.29	-41.0%	COM	N69605108
MAZE	Maze Therapeutics Inc	2,111,919	$25,913	20.9%	$12.04	-13.6%	COM	578784100
LYEL	Lyell Immunopharma, Inc.	800,399	$7,076	5.7%	$9.11	0.0%	COM	55083R203
XENE	Xenon Pharmaceuticals Inc	160,000	$5,008	4.0%	$32.62	0.0%	COM	98420N105
KURA	Kura Oncology, Inc.	816,882	$4,713	3.8%	$20.39	-70.0%	COM	50127T109
RLAY	Relay Therapeutics Inc.	1,000,000	$3,460	2.8%	$7.47	-60.2%	COM	75943R102